Fractyl
Hui Zhang currently serves as the Director of Biostatistics at Fractyl since June 2021 and holds the position of Associate Director of Biostatistics at Abiomed since April 2019. Their extensive experience in biostatistics positions him as a significant contributor in both organizations, enhancing their data analysis and research capabilities.
This person is not in any offices
Fractyl
2 followers
Fractyl aims to bring curative therapies to the large populations of patients with metabolic disease. With their innovative products, their goal is to truly shift the treatment paradigm for patients with metabolic disease by focusing on their root cause in the intestine to provide meaningful, transformative, benefits to restore patient health from metabolic diseases.